Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloset added to Metformin in T2DM
NCT00441363Phase 3Terminated
- Sponsor
- VeroScience
- Start
- Feb 2005
- Primary completion
- Feb 2006
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Cycloset + Metformin with Placebo + Metformin (2 arms). Primary endpoint: Change in Baseline to End of Study in HbA1c at 24 weeks. Started Feb 2005; status: terminated.
02
Drugs
bromocriptine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00441363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441363.